SC
Scancell Holdings plc
SCNLF · OTC
$0.14 +0.00% (+$0.00)
1M +4.29%
Market Cap £108.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 22.96x
P/FFO N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 260.50%
Op. margin 318.43%
FCF margin 136.13%
Quality
4 /100
Poor ROA 53.15%
Asset turnover 0.20x
ROIC 144.56%
Debt
10 /100
High Int. coverage -10.86x
Current ratio 0.77x
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 108.62%
Profitable years 0
Beta 0.74x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SCNLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Phillip John L'Huillier
Employees
61
Headquarters
Oxford
Evenimente viitoare
23 OCT.
Earnings
Upcoming earnings report
04 FEB.
Earnings
Upcoming earnings report